Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Date    |    Business Directory
All Press Releases for February 18, 2011 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Sasmar granted "Conceive Plus" Trademark for its Fertility Product in the United States
Sasmar, Inc. announced today that it has been granted Federal Trademark registration for its brand 'Conceive Plus', paving the way for release of its break-though fertility product to U.S. pharmacies and consumers in the second quarter of 2011. 
x-small text small text medium text large text


    CHICAGO, IL, February 18, 2011 /24-7PressRelease/ -- Sasmar, Inc. announced today that it has been granted Federal Trademark registration for its brand 'Conceive Plus', paving the way for release of its break-though fertility product to U.S. pharmacies and consumers in the second quarter of 2011.

Conceive Plus is the only lubricant that can contain Calcium and Magnesium ions based on patents filed internationally. Found naturally in fertile cervical and seminal fluid, Calcium and Magnesium ions play an essential role in sperm and egg viability and in the process of fertilization. By combining physiologically important ions in a pH and electrolyte balanced gel Conceive Plus better mimics fertile cervical fluid creating a conception friendly environment that feels natural and increases the likelihood of conception.

Conceive Plus is clinically tested safe for human sperm viability and motility, and safe for embryo development, whereas other lubricants can create a barrier or damage sperm or embryos and should be avoided when trying to get pregnant. Only Conceive Plus is approved to state that it "enhances sperm survival and motility" and "promotes Egg fertilization" and so is ideally suited for couples trying-to-conceive a baby naturally.

The success of the brand Conceive Plus reflects a different approach to connecting with consumers. By promoting unbiased information, clearly explaining the key differences and benefits of Conceive Plus encourages consumers to make an informed choice" Says CFO Andrew Soutter. "This is in contrast to others who promote disinformation and scientific scare tactics which puts consumers off....the product speaks for itself" This approach has allowed Sasmar to engage with thousands on Twitter and Facebook, who connect with and trust in the brand as a result.

Conceive Plus is recommended in leading retailers, fertility clinics, hospitals and pharmacies in over 30 countries globally including Australia, Singapore, Malaysia, Sri-Lanka, Germany and the United Kingdom. The range of Conceive Plus products are also available online from Amazon.com.

Information on published clinical studies and consumer testimonials is available at http://conceiveplus.com

SASMAR is a multinational pharmaceutical company headquartered in Belgium and operates in the areas of women's health, fertility and family planning. SASMAR is a major supplier of lubricants to international governmental organizations in HIV/AIDS prevention and awareness programs in third world and developing countries. The group has operations based in Sydney Australia, London United Kingdom, Chicago United States and has a presence in more than thirty countries through a network of distribution partners. More information on the company is available at http://www.sasmar.com


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #


Read more Press Releases from John-Michael Mancini:


Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Press Release Contact Information:
John-Michael Mancini
SASMAR

CEO
155 North Wacker Drive Suite 4250
Chicago, IL
United States 60606
Voice: 312 803 2619
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.